News

A Kobe University team was able to edit the DNA of Lactobacillus strains directly without a template from other organisms.
Pelthos Therapeutics, a Durham-based wholly owned subsidiary of Ligand Pharmaceuticals (Nasdaq: LGND), is combining with ...
Biotech firm 21st.BIO has developed a new strain of Aspergillus oryzae, a filamentous fungus commonly used in fermentation, ...
A Kobe University team was able to edit the DNA of Lactobacillus strains directly without a template from other organisms.
Pioneering research led by the University of Bristol has repurposed a gene-editing tool to help shed light on the true ...
A Kobe University team was able to edit the DNA of Lactobacillus strains directly without a template from other organisms.
Jaypee University of Information Technology, Waknaghat, Solan. Estd: 2002 Website: Star Courses: BTech and MTech programmes ...